Erin McGreehan (Louth, Fianna Fail)
Link to this: Individually | In context

1037. To ask the Minister for Health to outline the current eligibility criteria for access to continuous glucose monitoring (CGM) devices for people living with diabetes; the number of people currently waiting for a CGM device, disaggregated by age group and CHO area; the average wait time for device approval; and whether he will commit to ensuring equitable access to CGM devices for all diabetes patients who require them, including people with Type 2 diabetes, in line with best practice in other EU member states. [61704/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Erin McGreehan (Louth, Fianna Fail)
Link to this: Individually | In context

1038. To ask the Minister for Health the reason people with Type 1 diabetes, who are clinically entitled under national guidelines to access continuous glucose monitoring devices, continue to face prolonged waiting periods; the steps currently being taken to address these delays; and the date by which she expects waiting times to be brought within acceptable clinical standards. [61705/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Erin McGreehan (Louth, Fianna Fail)
Link to this: Individually | In context

1039. To ask the Minister for Health whether the Department or the HSE has commissioned or plans to commission a health technology assessment for the use of continuous glucose monitoring devices for people living with Type 2 diabetes; if not, the rationale for the delay; and if so, to provide a timeline for commencement, completion, and implementation of findings. [61706/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.